The ImmunOptimize Network is a national research network focused on advancing the prevention and treatment of
infectious diseases in immunocompromised populations. By bringing together clinicians, researchers, and institutions
across North America, the Network is building the infrastructure to support collaborative clinical trials and
generate evidence to inform infectious disease prevention and treatment. Our goal is to address critical gaps in research
and advance evidence-based guidance to protect immunocompromised populations.

Message sent on behalf of theImmunOptimize Network
Dear Colleagues,
We are conducting a research study to better understand healthcare provider attitudes, experiences, and institutional practices related to the use of monoclonal antibody (mAb) therapies for prevention or treatment of infections in immunocompromised patients.
We invite healthcare providers involved in the care of immunocompromised populations to participate in a brief anonymous online survey.
The survey takes approximately 10 minutes to complete. At the end of the survey, participants may optionally indicate their willingness to participate in a paid follow-up interview.
To participate, please complete the survey at: https://redcap.link/ION_mAb_Survey
Thank you for your participation.
Josh Hill, MD, FIDSA on behalf of the ImmunOptimize Network
Fred Hutch Cancer Center and University of Washington